ArticleRheumatology international2013

Baseline anti-citrullinated peptide antibody (ACPA) titers and serum interleukin-6 (IL-6) levels possibly predict progression of bone destruction in early stages of rheumatoid arthritis (ERA).

Yukihiko Saeki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.